BAM15 50mg Capsules: Dosage & Research Protocol Guide

BAM15 50mg Capsules Capsules Specifications

Peptide

BAM15 (Capsules) 50 mg / 60 ct (NNMT inhibitor)

Vial Content

50 mg BAM15 per capsule, 60 capsules per bottle (3,000 mg total)

Category

Metabolic / Weight Loss

Administration Method

Oral capsule

Common Use Case

Mitochondrial uncoupling for fat mass reduction and metabolic improvement

BAM15 Mechanism of Action

BAM15 is a protonophore that selectively transports protons across the inner mitochondrial membrane, dissipating the proton motive force as heat rather than ATP synthesis. This forces the mitochondria to increase substrate oxidation to maintain cellular energy, elevating basal metabolic rate and fat oxidation. Unlike classic uncouplers (DNP), BAM15 is proton-selective and does not significantly depolarize the plasma membrane, resulting in metabolic activation without dangerous systemic hyperthermia. Preclinical studies demonstrate significant reductions in fat mass and adipose tissue inflammation alongside improved insulin sensitivity.

BAM15 Research Findings and Observed Outcomes

Findings and reported areas of study for BAM15 (Capsules) 50 mg / 60 ct include:

• Significant fat mass reduction without caloric restriction in preclinical models
• Preserved lean body mass during fat loss (unlike severe caloric restriction)
• Improved insulin sensitivity and glucose metabolism
• Reduced mitochondrial ROS production
• No significant effect on core body temperature at research doses

These observations are discussed for research and educational reference only and are not medical claims.

BAM15 50mg Capsules Supplies for Use and Handling

• •BAM15 capsule bottle

Supplies listed are for laboratory handling and research preparation purposes only.

BAM15 Oral Route, Frequency and Timing

BAM15 Dosage Ranges

The ranges below pair the listed dose with the draw volume for this product strength.

BAM15 50mg Capsules Dosage Examples

Based on reconstitution below

This dosing table is unique to the 50 mg × 60 capsules vial. Units refer to markings on a standard U-100 insulin syringe (1 unit = 0.01 mL).

BAM15 50mg Capsules Duration by Research Dose

At common research doses, one 50 mg × 60 capsules vial of BAM15 typically supports:

Continuous daily use. Preclinical models used chronic administration. Monitor for tolerance.

BAM15 50mg Capsules Use and Handling Instructions

This section applies specifically to the BAM15 (Capsules) 50 mg / 60 ct.

Recommended Diluent

N/A — oral capsule

Diluent Volume

N/A

Final Concentration

50 mg per capsule

BAM15 and Compatible Research Pairings

In research settings, BAM15 (Capsules) 50 mg / 60 ct is sometimes paired with peptides such as:

• MOTS-c: Complementary mitochondrial metabolic activation via AMPK pathway
• AOD-9604: Adds beta-3 adrenergic fat oxidation pathway alongside mitochondrial uncoupling
• Semaglutide: GLP-1 appetite suppression combined with increased metabolic rate for enhanced fat loss

Supporting Factors for BAM15 Research

Factors recorded alongside this protocol include:

• Adequate hydration — mitochondrial uncoupling increases metabolic heat production
• Balanced protein intake to support lean mass during fat loss
• Regular aerobic exercise amplifies energy expenditure effects
• Avoid extreme heat environments during dosing due to increased thermogenesis

These factors can affect how research observations are interpreted.

BAM15 50mg Capsules Tolerability Notes

BAM15 has demonstrated a superior safety profile to classic uncouplers in preclinical models. Human data is limited — use with caution.

Some individuals report:

• Mild increase in sweating or body warmth (dose-dependent)
• GI discomfort if taken on an empty stomach
• Fatigue at higher doses
• Increased thirst and urination

BAM15 50mg Capsules Storage Requirements

Unreconstituted

Store at room temperature, away from moisture and light

Reconstituted

N/A

Post-Mix Stability

Stable as packaged; follow expiration date on bottle

This peptide is generally not recommended for:

• Pregnant or breastfeeding individuals
• Anyone with mitochondrial disorders
• Anyone with hyperthyroidism or elevated basal metabolic rate disorders
• Anyone advised otherwise by a qualified healthcare professional

BAM15 50mg Capsules Purchasing and Research Supply Notes

Before ordering BAM15 (Capsules) 50 mg / 60 ct, review the product label, available testing documents, and storage instructions.

Check the ResearchLabs listing for:

• Available testing documents
• Product strength and concentration
• Storage and handling instructions
• Current product availability

Confirm the product strength and storage requirements before ordering. Products are for laboratory research only and are not for human consumption.